Peripheral Stent Implants

Global Peripheral Stent Implants Market to Reach US$5.6 Billion by 2030

The global market for Peripheral Stent Implants estimated at US$4.0 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Bare Metal Stents, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Covered Stents segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 9.6% CAGR

The Peripheral Stent Implants market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Peripheral Stent Implants Market - Key Trends & Drivers Summarized

Why Are Peripheral Stent Implants Critical in Restoring Blood Flow in Arterial Disease?

Peripheral stent implants are medical devices used to open narrowed or blocked arteries in the limbs, particularly in cases of peripheral artery disease (PAD). These stents provide structural support to keep vessels open, restore blood circulation, and prevent complications such as tissue ischemia or amputation. They are deployed via catheter-based procedures, offering a minimally invasive alternative to surgical bypass.

PAD is strongly associated with diabetes, smoking, and aging, making stenting a central intervention in vascular medicine. Stents are particularly important in treating femoropopliteal and iliac artery blockages, where traditional angioplasty may not offer long-term patency. Continued refinement in stent design and deployment techniques is improving durability and patient outcomes.

How Are Technologies Advancing for Improved Efficacy and Safety?

Stent innovation is focused on increasing radial strength, flexibility, and long-term patency while minimizing restenosis and fracture. Nitinol-based self-expanding stents are widely used for peripheral vessels due to their adaptability to movement and vessel compression. Drug-eluting stents (DES) and drug-coated stents (DCS) release antiproliferative agents like paclitaxel to reduce the risk of re-narrowing.

Bioabsorbable stents, though still under evaluation, offer the potential for temporary scaffolding with reduced long-term complications. Improved stent delivery systems, low-profile catheters, and imaging-assisted placement tools are enhancing procedural precision. Additionally, new stents designed specifically for challenging anatomies such as below-the-knee (BTK) arteries are supporting expanded treatment indications.

Where Is Market Growth Concentrated and Which Conditions Are Driving Adoption?

Adoption is highest in vascular surgery centers, catheterization labs, and interventional radiology units across developed healthcare systems. North America and Europe lead in procedural volume due to well-established PAD screening and interventional infrastructure. Asia-Pacific is witnessing rapid growth in stent procedures driven by aging populations, increased prevalence of diabetes, and improving access to vascular care.

The primary drivers of stent implantation include intermittent claudication, critical limb ischemia, and chronic total occlusions. Device adoption is expanding in outpatient and ambulatory surgical centers as stenting procedures become more streamlined and less resource-intensive. Early-stage PAD management strategies are also incorporating stents to improve functional outcomes and prevent progression to severe limb ischemia.

Growth in the Peripheral Stent Implants market is driven by several factors…

Growth in the peripheral stent implants market is driven by factors such as rising incidence of peripheral artery disease, advancements in stent material and design, and growing preference for minimally invasive vascular interventions. Expanding clinical use of drug-eluting and self-expanding stents is improving long-term outcomes and supporting broader procedural adoption.

Improvements in stent visibility, flexibility, and compatibility with vessel dynamics are enhancing procedural safety. Increasing investments in outpatient endovascular procedures, supportive reimbursement policies, and training of interventional specialists are further fueling market expansion. As population aging and vascular risk factors continue to rise, peripheral stenting remains a cornerstone of PAD treatment strategies worldwide.

SCOPE OF STUDY:

The report analyzes the Peripheral Stent Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Bare Metal Stents, Covered Stents, Drug Eluting Stents); End-Use (Hospitals End-Use, Ambulatory Surgery Centers / Outpatient End-Use); Artery (Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents, Infrapop Artery Stents)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott
• Admedes GmbH
• Alvimedica
• B. Braun Melsungen AG
• Bentley InnoMed GmbH
• Biotronik
• Boston Scientific
• Cardinal Health
• Cook Medical
• Cordis
• Endologix LLC
• Gore Medical (W. L. Gore)
• iVascular
• JOTEC GmbH (CryoLife)
• Medinol
• Medtronic
• MicroPort Scientific
• SMT (Sahajanand Medical Tech)
• Terumo Corporation
• Translumina Therapeutics

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more